Latest Breaking News On - Phase 3 checkmate 901 trial nct03036098 - Page 1 : comparemela.com

Petros Grivas, MD, PhD, discusses outcomes associated with the phase 3 CheckMate 901 trial in metastatic or unresectable urothelial carcinoma, highlighting the importance of these data.

Petros grivasGenitourinary cancers programClinical research divisionSeattle cancer care allianceUniversity of washington uw school medicineFred hutchinson cancer research centerDivision of medical oncologyMedical oncologyMetastatic or unresectable urothelial carcinomaPhase 3 checkmate 901 trial nct03036098Nivolumab opdivo